SESTRI LEVANTE, LIGURIA — An 18-year-old woman is dead, prompting many young people in her area to cancel their previous plans for injections.
Ms. Camilla Canepa received the first dose of experimental
AstraZeneca viral vector DNA on May 25, according to several Italian
media sources. It was an “open day” for anyone over the age of 18 to
receive experimental injections, particularly AstraZeneca.
She checked into the emergency room at Lavagna Hospital on June 3,
complaining of severe headaches and extreme light sensitivity. A CT scan
and neurological tests found nothing, so doctors discharged her with an
order to return in 15 days for further tests. But Ms. Canepa returned
to the ER at San Martino Hospital in Genoa just two days later. She now
suffered from paralysis in at least one part of her body.
Ms. Canepa was diagnosed with cavernous sinus thrombosis,
meaning a blood clot in the space between the eye sockets and brain. It
blocked the primary vein between the head and heart. Doctors also
discovered that she was bleeding inside her brain.
Ms. Canepa underwent two surgeries, one to remove the blood clot and
the second to relieve pressure in her head caused by the bleeding. But
the damage was too great to overcome.
Ms. Canepa passed away on June 10.
Aftermath and “prosecution”
Francesco Cozzi, chief prosecutor of Genoa, announced that his office opened a manslaughter investigation.
However, he did not name any individuals subject to the investigation.
Further, we’ve heard this manslaughter talk before from Italian
prosecutors. Syracuse, Sicily prosecutors said they opened a manslaughter investigation after Navy officer Stefano Paternò died hours after the AstraZeneca shot.
But nothing has come of it, nor the other announced manslaughter
investigations throughout Italy related to the experimental shots.
Italian government officials announced a very strange policy after
the death of Ms. Canepa. AstraZeneca shots will now only be administered
to people over age 60.
In other words, they are fine with older people developing blood clots
and dying from experimental viral vector DNA shots, but are protecting
younger people. The policy didn’t matter in the grand scheme. Hundreds
of young Liguria residents cancelled their forthcoming AstraZeneca appointments as news of Ms. Canepa spread.
Liguria Governor Giovanni Toti told Ansa News that Canepa’s case is
“not for point scoring” and that AstraZeneca recipients volunteer for
the shots. Meanwhile the Italian Medicines Agency (AIFA) authorized the
experimental Pfizer mRNA shots for people aged 12 to 15 on June 1.
It is yet another strange policy that is apparently supposed to be
altruistic, but is dangerous and detrimental to future and current
generations of Italians.
https://www.italy24news.com/News/81533.html
https://www.newsy-today.com/doubts-about-the-death-of-18-year-old-camilla-canepa-parents-he-